Frame J W, Fisher S E, Pickvance N J, Skene A M
Br J Oral Maxillofac Surg. 1986 Apr;24(2):122-9. doi: 10.1016/0266-4356(86)90007-0.
In a double-blind, single dose study of analgesic efficacy, 165 patients who were expected to develop moderate to severe pain following the removal of an impacted mandibular third molar tooth were allocated to receive aspirin, placebo, or an increasing dose of a fixed ratio ibuprofen/codeine combination. The degree of pain experienced prior to medication was noted and the patients were asked to record the degree of pain and of pain relief hourly for the following 5 hours. The study produced clear evidence of the superior efficacy of the combinations when compared to placebo and aspirin. In addition, the high dose combination appeared to be superior with respect to pain relief and the need for additional analgesia compared to the low dose treatment. There were few side effects and only one severe reaction was reported by a patient in the high dose group. To avoid side effects it is suggested that the medium-dose combination, ibuprofen 400 mg/codeine 30 mg, is optimal.
在一项关于镇痛效果的双盲单剂量研究中,165名预计在拔除下颌阻生第三磨牙后会出现中度至重度疼痛的患者被分配接受阿司匹林、安慰剂或剂量递增的固定比例布洛芬/可待因组合药物。记录用药前的疼痛程度,并要求患者在接下来的5小时内每小时记录疼痛程度和疼痛缓解程度。该研究提供了明确证据,表明与安慰剂和阿司匹林相比,组合药物具有更优的疗效。此外,与低剂量治疗相比,高剂量组合在疼痛缓解和额外镇痛需求方面似乎更具优势。副作用很少,高剂量组仅有一名患者报告了严重反应。为避免副作用,建议中等剂量组合(布洛芬400毫克/可待因30毫克)为最佳选择。